2021
DOI: 10.1111/1346-8138.15888
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of skin fibrosis in systemic sclerosis by botulinum toxin B via the suppression of oxidative stress

Abstract: Oxidative stress has been reported to play an important role in the pathogenesis of skin fibrosis in systemic sclerosis (SSc). We previously identified that botulinum toxin (BTX) injection suppresses pressure ulcer formation in a cutaneous ischemia–reperfusion injury mouse model by regulation of oxidative stress. However, the therapeutic possibility of BTX administration for preventing skin fibrosis in SSc is unclear. The objective of this study was to investigate the effect of BTX‐B on skin fibrosis in a muri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 57 publications
0
3
0
Order By: Relevance
“…Several human skin pathologies, including SSc, are associated with significant redox imbalance at the cellular level [13,[47][48][49]. Antioxidant administration has also been reported to suppress skin and pulmonary fibrosis in SSc [50][51][52]. One example is Edaravone a novel, free radical scavenger and neuroprotective agent used in the treatment of acute Several human skin pathologies, including SSc, are associated with significant redox imbalance at the cellular level [13,[47][48][49].…”
Section: Inhibition Of Hocl-induced Skin and Lung Fibrosis By Twxmentioning
confidence: 99%
“…Several human skin pathologies, including SSc, are associated with significant redox imbalance at the cellular level [13,[47][48][49]. Antioxidant administration has also been reported to suppress skin and pulmonary fibrosis in SSc [50][51][52]. One example is Edaravone a novel, free radical scavenger and neuroprotective agent used in the treatment of acute Several human skin pathologies, including SSc, are associated with significant redox imbalance at the cellular level [13,[47][48][49].…”
Section: Inhibition Of Hocl-induced Skin and Lung Fibrosis By Twxmentioning
confidence: 99%
“…One example is Edaravone a novel, free radical scavenger and neuroprotective agent used in the treatment of acute Several human skin pathologies, including SSc, are associated with significant redox imbalance at the cellular level [13,[47][48][49]. Antioxidant administration has also been reported to suppress skin and pulmonary fibrosis in SSc [50][51][52]. One example is Edaravone, a novel, free radical scavenger and neuroprotective agent used in the treatment of acute embolic stroke in humans [53].…”
Section: Inhibition Of Hocl-induced Skin and Lung Fibrosis By Twxmentioning
confidence: 99%
“…[ 12 , 14 , 15 ], epilepsy [ 16 ], Huntington’s disease [ 17 , 18 ], diabetes mellitus [ 19 ], and multiple organ dysfunction syndrome [ 20 ]. In addition to that, oxidative stress is associated with mechanisms of psoriasis development [ 21 , 22 , 23 , 24 ] and with skin fibrosis in systemic scleroderma [ 25 ]. Oxidative stress, which is primarily caused by mitochondrial dysfunction, plays one of the leading roles in the processes of aging, both in tissues and in the whole organism [ 5 , 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%